Volumetric capnography for the evaluation of chronic airways diseases
Authors Veronez L, Pereira MC, Doria da Silva SM, Barcaui LA, De Capitani EM, Moreira MM, Paschoal IA
Received 22 February 2014
Accepted for publication 13 June 2014
Published 23 September 2014 Volume 2014:9(1) Pages 983—989
Checked for plagiarism Yes
Review by Single-blind
Peer reviewer comments 3
Liliani de Fátima Veronez,1 Monica Corso Pereira,2 Silvia Maria Doria da Silva,2 Luisa Affi Barcaui,2 Eduardo Mello De Capitani,2 Marcos Mello Moreira,2 Ilma Aparecida Paschoalz2
1Department of Physical Therapy, University of Votuporanga (Educational Foundation of Votuporanga), Votuporanga, 2Department of Internal Medicine, School of Medical Sciences, State University of Campinas (UNICAMP), Campinas, Sao Paulo, Brazil
Background: Obstructive lung diseases of different etiologies present with progressive peripheral airway involvement. The peripheral airways, known as the silent lung zone, are not adequately evaluated with conventional function tests. The principle of gas washout has been used to detect pulmonary ventilation inhomogeneity and to estimate the location of the underlying disease process. Volumetric capnography (VC) analyzes the pattern of CO2 elimination as a function of expired volume.
Objective: To measure normalized phase 3 slopes with VC in patients with non-cystic fibrosis bronchiectasis (NCB) and in bronchitic patients with chronic obstructive pulmonary disease (COPD) in order to compare the slopes obtained for the groups.
Methods: NCB and severe COPD were enrolled sequentially from an outpatient clinic (Hospital of the State University of Campinas). A control group was established for the NCB group, paired by sex and age. All subjects performed spirometry, VC, and the 6-Minute Walk Test (6MWT). Two comparisons were made: NCB group versus its control group, and NCB group versus COPD group. The project was approved by the ethical committee of the institution. Statistical tests used were Wilcoxon or Student’s t-test; P<0.05 was considered to be a statistically significant difference.
Results: Concerning the NCB group (N=20) versus the control group (N=20), significant differences were found in body mass index and in several functional variables (spirometric, VC, 6MWT) with worse results observed in the NCB group. In the comparison between the COPD group (N=20) versus the NCB group, although patients with COPD had worse spirometric and 6MWT values, the capnographic variables mean phase 2 slope (Slp2), mean phase 3 slope normalized by the mean expiratory volume, or mean phase 3 slope normalized by the end-tidal CO2 concentration were similar.
Conclusion: These findings may indicate that the gas elimination curves are not sensitive enough to monitor the severity of structural abnormalities. The role of normalized phase 3 slope may be worth exploring as a more sensitive index of small airway disease, even though it may not be equally sensitive in discriminating the severity of the alterations.
Keywords: volumetric capnography, spirometry, bronchiectasis, 6MWT, bronchitis
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.Download Article [PDF] View Full Text [HTML][Machine readable]
Readers of this article also read:
Comparison of the BPLab® sphygmomanometer for ambulatory blood pressure monitoring with mercury sphygmomanometry in pregnant women: validation study according to the British Hypertension Society protocol
Dorogova IV, Panina ES
Published Date: 13 April 2015
Do frequent moderate exacerbations contribute to progression of chronic obstructive pulmonary disease in patients who are ex-smokers?
Dreyse J, Díaz O, Repetto PB, Morales A, Saldías F, Lisboa C
Published Date: 10 March 2015
Systematic literature review of patient-reported outcome measures used in assessment and measurement of sleep disorders in chronic obstructive pulmonary disease
Garrow AP, Yorke J, Khan N, Vestbo J, Singh D, Tyson S
Published Date: 9 February 2015
Influence of immune activation and inflammatory response on cardiovascular risk associated with the human immunodeficiency virus
Beltrán LM, Rubio-Navarro A, Amaro-Villalobos JM, Egido J, García-Puig J, Moreno JA
Published Date: 6 January 2015
Soler-Cataluña JJ, Alcázar-Navarrete B, Miravitlles M
Published Date: 12 December 2014
Santos SR, Lizzi ES, Vianna EO
Published Date: 15 October 2014
Efficacy and safety of combining olodaterol Respimat® and tiotropium HandiHaler® in patients with COPD: results of two randomized, double-blind, active-controlled studies
ZuWallack R, Allen L, Hernandez G, Ting N, Abrahams R
Published Date: 14 October 2014
Sex-specific relationships between adverse childhood experiences and chronic obstructive pulmonary disease in five states
Cunningham TJ, Ford ES, Croft JB, Merrick MT, Rolle IV, Giles WH
Published Date: 26 September 2014
Airway epithelial platelet-activating factor receptor expression is markedly upregulated in chronic obstructive pulmonary disease
Shukla SD, Sohal SS, Mahmood MQ, Reid D, Muller HK, Walters EH
Published Date: 13 August 2014